The publication is reproduced in full below:
EXECUTIVE COMMUNICATIONS, ETC.
Under clause 2 of rule XIV, executive communications were taken from the Speaker's table and referred as follows:
EC-2517. A letter from the Assistant Secretary, Securities and Exchange Commission, transmitting the Commission's final rule -- Filing Fee Disclosure and Payment Methods Modernization [Release Nos.: 33-10997; 34-93285; IC-34396; File No. S7-20-19] (RIN: 3235-AL96) received October 20, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Financial Services.
EC-2518. A letter from the Senior Policy Analyst, Office of the Under Secretary for Economic Affairs, Department of Commerce, transmitting the Department's final rule -- Concrete Masonry Products Research, Education, and Promotion Order [Docket No.: 210820-0165] (RIN: 0605-AA53) received September 30, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Energy and Commerce.
EC-2519. A letter from the Director, Regulations Policy and Management Staff, FDA, Department of Health and Human Services, transmitting the Department's final rule -- Listing of Color Additives Exempt From Certification; Silver Nitrate
[Docket No.: FDA-2018-C-0617] received October 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Energy and Commerce.
EC-2520. A letter from the Director, Regulations Policy and Management Staff, FDA, Department of Health and Human Services, transmitting the Department's final rule -- Medical Device De Novo Classification Process [Docket No.: FDA-2018-N-0236] (RIN: 0910-AH53) received October 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Energy and Commerce.
EC-2521. A letter from the Director, Regulations Policy and Management Staff, FDA, Department of Health and Human Services, transmitting the Department's final rule -- Premarket Tobacco Product Applications and Recordkeeping Requirements [Docket No.: FDA-2019-N-2854] (RIN: 0910-AH44) received October 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Energy and Commerce.
EC-2522. A letter from the Director, Regulations Policy and Management Staff, FDA, Department of Health and Human Services, transmitting the Department's final rule -- Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports
[Docket No.: FDA-2016-N-3818] (RIN: 0910-AH89) received October 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Energy and Commerce.
EC-2523. A letter from the Associate Division Director, Regulatory Management Division, Environmental Protection Agency, transmitting the Agency's final rule -- Air Plan Approval; California; Antelope Valley Air Quality Management District, Eastern Kern Air Pollution Control District, and Yolo-Solano Air Quality Management District; Combustion Sources; Correcting Amendment [EPA-R09-OAR-2020-0476; FRL-8777-03-R9] received October 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Energy and Commerce.
EC-2524. A letter from the Associate Division Director, Regulatory Management Division, Environmental Protection Agency, transmitting the Agency's final rule -- Pseudomonas Fluorescens Strain ACK55; Exemption From the Requirement of a Tolerance; Technical Correction [EPA-HQ-OPP-2017-0335; FRL-9000-01-OCSPP] received October 14, 2021], pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Energy and Commerce.
EC-2525. A letter from the Associate Division Director, Regulatory Management Division, Environmental Protection Agency, transmitting the Agency's final rule -- Significant New Use Rules on Certain Chemical Substances (21-2.B) [EPA-HQ-OPPT-2020-0581; FRL-8585-01-OCSPP] (RIN: 2070-AB27) received October 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Energy and Commerce.
EC-2526. A letter from the Associate Division Director, Regulatory Management Division, Environmental Protection Agency, transmitting the Agency's final rule -- Clothianidin; Pesticide Tolerances [EPA-HQ-OPP-2020-0511; FRL-8667-01-OCSPP] received October 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Energy and Commerce.
EC-2527. A letter from the Associate Division Director, Regulatory Management Division, Environmental Protection Agency, transmitting the Agency's correcting amendment -- Clean Air Plans; 2008 8-Hour Ozone Nonattainment Area Requirements; West Mojave Desert, California [EPA-R09-OAR-2020-0254; FRL-8727-03-R9] received October 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Energy and Commerce.
EC-2528. A letter from the Director, Office of Regulatory Affairs and C.A., Bureau of Indian Affairs, Department of the Interior, transmitting the Department's final rule -- Indian Land Title and Records [212A2100DD/AAKC001030/A0A501010.999900] (RIN: 1076-AF56) received October 25, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Natural Resources.
EC-2529. A letter from the Adjutant General, Veterans of Foreign Wars, transmitting the proceedings of the 121st National Pro-Forma Convention of the Veterans of Foreign Wars of the United States, held in Kansas City, Missouri, July 24, 2020, pursuant to 44 U.S.C. 1332; Public Law 90-620 (as amended by Public Law 105-225, Sec. 3); (112 Stat. 1498) (H. Doc. No. 117--68); to the Committee on Veterans' Affairs and ordered to be printed.
EC-2530. A letter from the Director, Legal Processing Division, Internal Revenue Service, transmitting the Service's Major final rule -- Requirements Related to Surprise Billing; Part II [TD 9955] (RIN: 1545-BQ05) received October 19, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Ways and Means.
EC-2531. A letter from the Director, Legal Processing Division, Internal Revenue Service, transmitting the Service's final rule -- Certain Non-Government Persons Not Authorized To Participate in Examinations of Books and Witnesses as a Section 6103(n) Contractor [TD 9952] (RIN: 1545-B012) received October 8, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Ways and Means.
EC-2532. A letter from the Director, Legal Processing Division, Internal Revenue Service, transmitting the Service's IRB only rule -- Revenue Procedure: Examination of returns and claims for refund, credit, or abatement; determination of correct tax liability (Rev. Proc. 2021-41) received October 8, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on Ways and Means.
____________________
SOURCE: Congressional Record Vol. 167, No. 188
The Congressional Record is a unique source of public documentation. It started in 1873, documenting nearly all the major and minor policies being discussed and debated.
House Representatives' salaries are historically higher than the median US income.
Alerts Sign-up